At Phenix, we focus on high-need therapeutic areas with small prescriber bases. Through global partnerships, we in-license late-stage or approved assets from emerging biopharma innovators to deliver meaningful impact for patients and providers in Canada
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
